Impact of percutaneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal XXXX outside the hospital.

@entity1 @entity63 @entity1167 @entity453 @entity943
Survivors of @entity1167 due to @entity943 are at risk for recurrent events. The role of revascularization in secondary prevention for survivors of @entity1167 has been addressed in various studies with conflicting results. A total of 142 survivors of @entity1167 with @entity453 were evaluated according to a standardized protocol, including 2-dimensional echocardiography, myocardial perfusion scintigraphy, coronary angiography, and electrophysiologic testing. Revascularization of scintigraphically documented @entity63 myocardial regions was performed in 44 @entity1 (31%). Final therapy was based on the results of electrophysiologic testing. Four-year survival rates were 100% for revascularized noninducible @entity1 , 84% for revascularized inducible @entity1 , 91% for nonrevascularized noninducible @entity1 , and 72% for nonrevascularized inducible @entity1 . Only 1 @entity1 (<1% of study population) died suddenly. Recurrences were much more frequent in @entity1 without revascularization (38% vs 7%, p <0.001) and the recurrence rate was 0% in the revascularized noninducible @entity1 . Thus, revascularization of ischemically jeopardized myocardium in survivors of @entity1167 resulted in excellent survival; moreover, in absence of inducible @entity943 , the recurrence rate was 0%. Systematic evaluation of survivors of @entity1167 due to @entity943 allows risk stratification and guidance of subsequent antiarrhythmic therapy.
